Filing Details

Accession Number:
0001209191-23-027361
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2023-05-04 16:38:07
Reporting Period:
2023-04-12
Accepted Time:
2023-05-04 16:38:07
Original Submission Date:
2023-04-14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
25743 Therapeuticsmd Inc. TXMD Pharmaceutical Preparations (2834) 870233535
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1820187 D Marlan Walker 951 Yamato Road
Suite 220
Boca Raton FL 33431
Chief Executive Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-04-26 1,010 $0.00 14,041 No 4 M Direct
Common Stock Acquisiton 2023-04-26 1,734 $0.00 12,307 No 4 M Direct
Common Stock Disposition 2023-04-26 692 $3.64 11,615 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2023-04-26 1,010 $0.00 1,010 $0.00
Common Stock Restricted Stock Units Disposition 2023-04-26 1,734 $0.00 1,734 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
3,466 No 4 M Direct
Footnotes
  1. The beneficially owned shares have been adjusted as the restricted stock units previously reported as settled on April 12, 2023 were not settled on that date. The restricted stock units settled on April 26, 2023.
  2. The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations.
  3. Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs vested in three equal installments annually, becoming fully vested on March 30, 2023.
  4. Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 23, 2023, becoming fully vested on March 23, 2025.